- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Joanna Breitstein
Joanna Breitstein
Executive Editor
jbreitstein@advanstar.com
Joanna Breitstein is executive editor at Pharmaceutical Executive magazine, and has been with the publication since November 2000. During that time, she's interviewed countless CEOs and other pharma executives for cover stories and feature articles on all aspects of the development and commercialization of pharmaceuticals. In 2004, Joanna won a fellowship from the Kaiser Family Foundation to travel to Africa and report on AIDS drug distribution under President Bush's PEPFAR grant, resulting in a two-part series on the topic. Joanna also won a Neal Award, for excellence in business journalism, in 2002 for her cover story focusing on the coverage of diagnostics and pharmaceuticals, and a Grand Neal Award in 2001, for a cover story on patient advocacy in oncology. Before joining Pharmaceutical Executive, Joanna deepened her knowledge of the pharma industry and several treatment categories within the health and medical group at Ogilvy Public Relations Worldwide. She is also president of the international HUG Foundation, a 501c3 organization whose mission is to help needy orphans in Uganda.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
